⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

BridgeBio Oncology Therapeutics, Inc. Common Stock

$9.34
+0.09 (+0.97%)

Volume:

288.756K ($2.67M)

Market Capitalization:

$748.20M

BridgeBio Oncology Therapeutics Price Chart

BridgeBio Oncology Therapeutics Price Chart12:00 PM1:20 PM2:40 PM4:00 PM5:20 PM6:40 PM8:00 PM9.549.489.439.389.329.279.21

BridgeBio Oncology Therapeutics Volume Chart

BridgeBio Oncology Therapeutics Volume Chart12:00 PM1:20 PM2:40 PM4:00 PM5:20 PM6:40 PM8:00 PM24.66K21.14K17.62K14.09K10.57K7.05K3.52K

BridgeBio Oncology Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.11(+1.19%)
Open$9.23
Close$9.34
Low$9.23
Low Change0.00 (0.00%)
High$9.34
High Change+0.11 (+1.19%)
Range$0.11
Volume25.165K
Dollar Volume$235.04K

Regular Trading Hours

-0.23(-2.43%)
Open$9.48
Close$9.25
Low$9.20
Low Change-0.28 (-2.95%)
High$9.61
High Change+0.13 (+1.37%)
Range$0.41
Volume263.591K
Dollar Volume$2.44M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.11(+1.19%)
Open$9.23
Close$9.34
Low$9.23
Low Change0.00 (0.00%)
High$9.34
High Change+0.11 (+1.19%)
Range$0.11
Volume25.165K
Dollar Volume$235.04K

Regular Trading Hours Yesterday

-0.23(-2.43%)
Open$9.48
Close$9.25
Low$9.20
Low Change-0.28 (-2.95%)
High$9.61
High Change+0.13 (+1.37%)
Range$0.41
Volume263.591K
Dollar Volume$2.44M

Premarket Yesterday

*No Trades in Segment

BridgeBio Oncology Therapeutics Top Trades

BridgeBio Oncology Therapeutics's top trade so far today returned +1.52%, while the top short trade returned -3.95%.

BridgeBio Oncology Therapeutics Moving Averages

5 Day Moving Average (SMA5)$9.30
10 Day Moving Average (SMA10)$8.94
20 Day Moving Average (SMA20)$8.78
50 Day Moving Average (SMA50)$8.28
100 Day Moving Average (SMA100)$8.49
200 Day Moving Average (SMA200)$10.03

BridgeBio Oncology Therapeutics Statistics

Average Volume (30 Days)327.58K
P/E Ratio (Current)-4.15
EPS (Current)-$2.27
Dividend Yield0.00%
Free Cash Flow-$193.82M
Cash Ratio1.05
Current Ratio4.69
Quick Ratio4.69
Debt to Equity0.00
Enterprise Value$701.18M
EV to EBITDA-3.54
EV to Sales
Price to Book2.34
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.48%
Return on Equity-0.56%

BridgeBio Oncology Therapeutics Stock Splits

There have been no stock splits for BridgeBio Oncology Therapeutics (BBOT).

BridgeBio Oncology Therapeutics Dividends

There have been no dividends for BridgeBio Oncology Therapeutics (BBOT).